{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:45:19Z","timestamp":1794278719753,"version":"4.9.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R01DA045729"],"award-info":[{"award-number":["R01DA045729"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"crossref","award":["#75821"],"award-info":[{"award-number":["#75821"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Background: Medications for opioid use disorder (MOUD) improve outcomes for pregnant women and infants. Our primary aim was to examine disparities in maternal MOUD receipt by family sociodemographic characteristics. Methods: This retrospective cohort study included mother-infant dyads with Medicaid-covered deliveries in Tennessee from 2009 to 2016. First, we examined family sociodemographic characteristics \u2013 including race\/ethnicity, rurality, mother's primary language and education level, and whether paternity was recorded in birth records \u2013 and newborn outcomes by type of maternal opioid use. Second, among pregnant women with OUD, we used logistic regression to measure disparities in receipt of MOUD by family sociodemographic characteristics including interactions between characteristics. Results: Our cohort from Medicaid-covered deliveries consisted of 314,965 mother-infant dyads, and 4.2 percent were exposed to opioids through maternal use. Among dyads with maternal OUD, MOUD receipt was associated with lower rates of preterm and very preterm birth. Logistic regression adjusted for family sociodemographic characteristics showed that pregnant women with OUD in rural versus urban areas (aOR: 0.66; 95% CI: 0.60\u20130.72) and who were aged \u226535\u2009years versus \u226425\u2009years (aOR: 0.75; 95% CI: 0.64\u20130.89) were less likely to have received MOUD. Families in which the mother's primary language was English (aOR: 2.47; 95% CI: 1.24\u20134.91) and paternity was recorded on the birth certificate (aOR: 1.30; 95% CI: 1.19\u20131.42) were more likely to have received MOUD. Regardless of high school degree attainment, non-Hispanic Black versus non-Hispanic White race was associated with lower likelihood of MOUD receipt. Hispanic race was associated with lower likelihood of MOUD receipt among women without a high school degree. Conclusions: Among a large cohort of pregnant women, we found disparities in receipt of MOUD among non-Hispanic Black, Hispanic, and rural pregnant women. As policymakers consider strategies to improve access to MOUD, they should consider targeted approaches to address these disparities.<\/jats:p>","DOI":"10.1080\/08897077.2021.1949664","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T14:04:02Z","timestamp":1626444242000},"page":"508-513","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":45,"title":["Disparities in Receipt of Medications for Opioid use Disorder among Pregnant Women"],"prefix":"10.1177","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-4549","authenticated-orcid":false,"given":"Laura E.","family":"Henkhaus","sequence":"first","affiliation":[{"name":"Data Science Institute, Vanderbilt University, Nashville, Tennessee, USA"},{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda B.","family":"Buntin","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Clark","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pikki","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Patrick","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"},{"name":"Mildred Stahlman Division of Neonatology, Vanderbilt University, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.3750"},{"key":"bibr2-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3520"},{"key":"bibr3-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000208"},{"key":"bibr4-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029074"},{"key":"bibr5-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m772"},{"key":"bibr6-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.04.028"},{"key":"bibr7-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1111\/add.13462"},{"key":"bibr8-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx341"},{"key":"bibr9-08897077.2021.1949664","unstructured":"United States Congress. S.524\u2013Comprehensive Addiction and Recovery Act of 2016. Public Law No. 114-198. https:\/\/www.congress.gov\/bill\/114th-congress\/senate-bill\/524\/text. Accessed November 13, 2020."},{"key":"bibr10-08897077.2021.1949664","volume-title":"The President's Commission on Combating Drug Addiction and the Opioid Crisis: final Report","author":"Christie C","year":"2017"},{"key":"bibr11-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.7326\/M19-2403"},{"key":"bibr12-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1624"},{"key":"bibr13-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5734"},{"key":"bibr14-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.13456"},{"key":"bibr15-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1488336"},{"key":"bibr16-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2011.300558"},{"key":"bibr17-08897077.2021.1949664","unstructured":"Kaiser Family Foundation. Medicaid and CHIP income eligibility limits for pregnant women, 2003\u20132021. https:\/\/www.kff.org\/medicaid\/state-indicator\/medicaid-and-chip-income-eligibility-limits-for-pregnant-women\/. Published 2021. Accessed May 12, 2021."},{"key":"bibr18-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116736"},{"key":"bibr19-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115692"},{"key":"bibr20-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4183"},{"key":"bibr21-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2018-0227"},{"key":"bibr22-08897077.2021.1949664","unstructured":"Moore B, Barrett M. Case study: exploring how opioid-related diagnosis codes translate from ICD-9-CM to ICD-10-CM.\n                      US Agency for Healthcare Research and Quality.\n                      https:\/\/www.hcup-us.ahrq.gov\/datainnovations\/ICD-10CaseStudyonOpioid-RelatedIPStays042417.pdf. Published April 24, 2017. Accessed July 12, 2020."},{"key":"bibr23-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189900"},{"key":"bibr24-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-013-9341-3"},{"key":"bibr25-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1177\/2332649215626936"},{"key":"bibr26-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2012.01410.x"},{"key":"bibr27-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199977260.003.0006"},{"key":"bibr28-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-040218-043750"},{"key":"bibr29-08897077.2021.1949664","volume-title":"HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder [Press Release]","year":"2021"},{"key":"bibr30-08897077.2021.1949664","unstructured":"United States Department of Health and Human Services. 42 CFR part 8\u2013medication assisted treatment for opioid use disorders. https:\/\/www.federalregister.gov\/documents\/2016\/07\/08\/2016-16120\/medication-assisted-treatment-for-opioid-use-disorders. Published July 8, 2016. Accessed January 5, 2021."},{"key":"bibr31-08897077.2021.1949664","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0834"},{"key":"bibr32-08897077.2021.1949664","unstructured":"Tennessee Code Annotated, Public Chapter 761, 2020."},{"key":"bibr33-08897077.2021.1949664","unstructured":"Tennessee Code Annotated, Public Chapter 771, 2020."},{"key":"bibr34-08897077.2021.1949664","unstructured":"Tennessee Division of TennCare. TennCare's opioid strategy. https:\/\/www.tn.gov\/tenncare\/tenncare-s-opioid-strategy.html. Published 2020. Accessed November 13, 2020."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1949664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1949664","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1949664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:32Z","timestamp":1777625732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1949664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2021.1949664"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1949664","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}